Mercanto Holdings Inc. develops and sells instant wellness beverages, including cannabis, probiotics, and functional mushrooms. The company shows strong financial health with a gross margin of 37.6% and a solid ROE of 24.1%, indicating effective management and profitability. However, the quick ratio of 0.72 suggests potential liquidity concerns, and the low market cap of $6.20M raises questions about valuation despite healthy margins. Overall, while the company has promising metrics, its market position and liquidity warrant cautious consideration.
Loading financial metrics...
No significant red flags identified
This company appears financially healthy on available metrics
Exceptional revenue growth of 52.9% YoY demonstrates strong market demand and competitive positioning.
Operating margin expanded by 13.0pp, demonstrating strong operational leverage.
Operating cash flow surged 2476.3% YoY, indicating strong cash generation capability.
Debt-free balance sheet with a solid cash position, providing significant financial flexibility.
Low debt-to-revenue ratio of 0.0% indicates conservative financial management.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Drug Manufacturers - Specialty & Generic companies of a similar size
Based on 2026-Q3 (April 30, 2026)